Management of the Febrile Young Infant: Update for the 21st Century

Area of Science:

• Pediatrics
• Infectious Diseases
• Clinical Diagnostics

Background:

• Febrile infants under 90 days old frequently require pediatric emergency department evaluation.
• Distinguishing benign viral from serious bacterial infections in infants is difficult using physical exams and traditional labs.
• Existing clinical prediction models have limitations in specificity for identifying bacterial infections.

Purpose of the Study:

• To review the diagnostic utility of various biomarkers for serious bacterial infections in febrile infants.
• To assess the effectiveness of novel biomarkers compared to traditional methods.
• To highlight the potential of new diagnostic approaches in pediatric emergency care.

Main Methods:

• Review of existing literature on diagnostic tests for febrile infants.
• Comparison of traditional laboratory studies (e.g., white blood cell count) with newer biomarkers (C-reactive protein, procalcitonin).
• Evaluation of clinical prediction models and emerging RNA biosignatures.

Main Results:

• C-reactive protein and procalcitonin demonstrate favorable test characteristics over white blood cell counts.
• Novel biomarkers show high sensitivity for detecting serious bacterial infections when combined with clinical data.
• Challenges to widespread acceptance of novel biomarkers include data limitations and varying criteria.

Conclusions:

• C-reactive protein and procalcitonin offer improved diagnostic accuracy for serious bacterial infections in febrile infants.
• Further research with robust data is needed to fully integrate novel biomarkers into clinical practice.
• RNA biosignatures represent a promising area for future investigation in diagnosing infant infections.